Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1976 1
1977 1
1983 1
1994 1
2003 1
2005 1
2006 1
2007 1
2010 2
2011 1
2012 1
2013 1
2014 2
2015 6
2016 5
2017 3
2018 3
2019 3
2020 7
2021 5
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Recurrent Laryngeal Nerve Stimulator.
Mueller AH, Pototschnig C. Mueller AH, et al. Otolaryngol Clin North Am. 2020 Feb;53(1):145-156. doi: 10.1016/j.otc.2019.09.009. Epub 2019 Oct 21. Otolaryngol Clin North Am. 2020. PMID: 31648825 Review.
Electromyography of the posterior cricoarytenoid muscles: a consensus guideline.
Foerster G, Bach A, Gorriz C, Guntinas-Lichius O, Klinge K, Leonhard M, Pototschnig C, Schneider-Stickler B, Volk GF, Mueller AH. Foerster G, et al. Among authors: mueller ah. Eur Arch Otorhinolaryngol. 2022 Aug;279(8):3785-3793. doi: 10.1007/s00405-022-07357-z. Epub 2022 Apr 30. Eur Arch Otorhinolaryngol. 2022. PMID: 35488126 Review.
Laryngeal pacing for bilateral vocal fold immobility.
Mueller AH. Mueller AH. Curr Opin Otolaryngol Head Neck Surg. 2011 Dec;19(6):439-43. doi: 10.1097/MOO.0b013e32834cb7ba. Curr Opin Otolaryngol Head Neck Surg. 2011. PMID: 22001660 Review.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
47 results